The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment patterns for extramedullary multiple myeloma and outcomes with CAR-T therapy and bispecific antibodies.
 
Saurabh Zanwar
No Relationships to Disclose
 
Matthew Ho
No Relationships to Disclose
 
Prashant Kapoor
Honoraria - BeiGene; Cellectar; Clinical Care Options/NCCN; GlaxoSmithKline (Inst); Karyopharm Therapeutics; Pharmacyclics; Sanofi (Inst)
Consulting or Advisory Role - Sanofi (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst); Regeneron (Inst); Sanofi (Inst); Sorrento Therapeutics (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Janssen; Sanofi
 
Moritz Binder
No Relationships to Disclose
 
Francis Buadi
No Relationships to Disclose
 
Angela Dispenzieri
Consulting or Advisory Role - Janssen Research & Development
Research Funding - Alnylam (Inst); Celgene (Inst); Janssen Oncology (Inst); Pfizer (Inst); Prothena; Takeda (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Pfizer; Prothena
 
David Dingli
No Relationships to Disclose
 
Amie L. Fonder
No Relationships to Disclose
 
Morie A. Gertz
Honoraria - Abbvie; Akcea Therapeutics; Alnylam; Amgen; Apellis Pharmaceuticals; Celgene; Janssen Oncology; Juno/Celgene; Med Learning Group; Prothena; Research to Practice; Sanofi; Telix Pharmaceuticals
Consulting or Advisory Role - Bristol-Myers Squibb/Sanofi; Prothena
Travel, Accommodations, Expenses - Celgene; Novartis; Prothena
 
Wilson I. Gonsalves
Consulting or Advisory Role - Amgen (Inst)
Research Funding - Bristol Myers Squibb Foundation (Inst); ORIC Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Patent number: 10996224: Assessing and treating precursor plasma cell disorders
 
Suzanne R. Hayman
No Relationships to Disclose
 
Yi Lisa Hwa
Consulting or Advisory Role - Akcea Therapeutics; Sanofi (Inst)
 
Miriam A. Hobbs
No Relationships to Disclose
 
Taxiarchis Kourelis
No Relationships to Disclose
 
Martha Lacy
No Relationships to Disclose
 
Nelson Leung
Stock and Other Ownership Interests - Abbvie; senseonics; Verrica Pharmaceuticals
Research Funding - Omeros
 
Eli Muchtar
Honoraria - Janssen
Consulting or Advisory Role - Protego Biopharma
 
Rahma M. Warsame
No Relationships to Disclose
 
S. Vincent Rajkumar
No Relationships to Disclose
 
Shaji Kumar
Honoraria - BeiGene; Guangzhou Link Health Pharma; Secura Bio
Consulting or Advisory Role - Abbvie (Inst); Abbvie (Inst); Amgen (Inst); Bluebird Bio (Inst); Celgene (Inst); Genecentrix; Genentech/Roche (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); Molecular Partners (Inst); Oncopeptides; Takeda (Inst)
Research Funding - Abbvie (Inst); CARsgen Therapeutics (Inst); Celgene (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst); TeneoBio (Inst)